Alzheimer-2015 May


1. Common genetic variants on 6q24 associated with exceptional episodic memory performance in the elderly. JAMA Neurol. 2014 Dec;71(12):1514-9.

3. Fatty acid profiles in demented patients: identification of hexacosanoic acid (C26:0) as a blood lipid biomarker of dementia. J Alzheimers Dis. 2015;44(4):1349-59.

5. Visuospatial learning and memory in the Cebus apella and microglial morphology in the molecular layer of the dentate gyrus and CA1 lacunosum molecular layer. Journal of Chemical Neuroanatomy.2014 Nov;61-62:176-188.

7. Afferent and efferent immunological pathways of the brain. Anatomy, function and failure. Brain Behav Immun. 2014 Feb;36:9-14.

9. miR-126 regulates growth factor activities and vulnerability to toxic insult in neurons. Mol. Neurobiol. 2014; Nov. 19

11. Social interaction rescues memory deficit in an animal model of Alzheimer’s disease by increasing BDNF-dependent hippocampal neurogenesis. J Neurosci. 2014 Dec 3;34(49):16207-19.

15. BDNF impairment is associated with age-related changes in the inner retina and exacerbates experimental glaucoma. Biochim Biophys Acta. 2014 Sep;1842(9):1567-78.

vs fig117. Abeta(1-42) enhances neuronal excitability in the CA1 via NR2B subunit-containing NMDA receptors. Neural Plast. 2014;2014:584314.





19. Exendin-4 promotes the membrane trafficking of the AMPA receptor GluR1 subunit and ADAM10 in the mouse neocortex. Regul Pept. 2014 May;190-191:1-11.

21. Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells. PLoS One. 2014 Aug 29;9(8):e106533.

23. Gait velocity is an indicator of cognitive performance in healthy middle-aged adults. PLoS One. 2014 Aug 4;9(8):e103211.

25. Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriers. Neurology 2013 Oct 8; 81(15):1322-31.

DK FIG226. Screening for traumatic brain injury: findings and public health implications. J Head Trauma Rehabil. 2014 Nov-Dec;29(6):479-89.



28. Human FGF1 promoter is active in ependymal cells and dopaminergic neurons in the brains of F1B-GFP transgenic mice. Dev Neurobiol. 2015 Mar;75(3):232-48.

30. Fibroblast Aggregation Rate Converges with Validated Peripheral Biomarkers for Alzheimer’s Disease. J Alzheimers Dis. 2014;42(4):1279-94.


2. Temporal-logic analysis of microglial phenotypic conversion with exposure to amyloid-β. Mol Biosyst. 2015 Feb;11(2):434-53.

4. Different effect of vitamin D2 and vitamin D3 on amyloid-β40 aggregation in vitro. Curr Alzheimer Res. 2014;11(8):745-54.

6. Reversible cholinesterase inhibitors as pre-treatment for exposure to organophosphates: assessment using azinphos-methyl. J Appl Toxicol. 2015 May;35(5):493-9.

8. Calcium-sensing receptors of human astrocyte-neuron teams: amyloid-β-driven mediators and therapeutic targets of Alzheimer’s disease. Curr Neuropharmacol. 2014 12(4):353-364.

10. The prevalence of dementia subtypes in rural Tanzania. Am J Geriatr Psychiatry. 2014 Dec;22(12):1613-22.

12. Reduced aggregation and cytotoxicity of amyloid peptides by graphene oxide/gold nanocomposites prepared by pulsed laser ablation in water. Small. 2014 Nov 12;10(21):4386-94.

fig 2 Saretzki frontiers14. The role of telomerase protein TERT in Alzheimer’s disease and in tau-related pathology in vitro. J Neurosci. 2015 Jan 28;35(4):1659-74.


16. Proteins in aggregates functionally impact multiple neurodegenerative disease models by forming proteasome-blocking complexes. Aging Cell. 2015 Feb;14(1):35-48.

WBF picture18. Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer’s disease treatment. Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):E3825-30.


20. Inhibition of stress induced premature senescence in presenilin-1 mutated cells with water soluble Coenzyme Q10. Mitochondrion. 2014 Jul;17:106-15.

22. The 5 Objects Test: a novel, minimal-language, memory screening test. J Neurol. 2014 Feb;261(2):422-31.

Figure_124. Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice. Neurobiol Dis. 2015 Feb;74:204-18.



27. Objectively measured physical activity, brain atrophy, and white matter lesions in older adults with mild cognitive impairment. Exp Gerontol. 2015 Feb;62:1-6.

Figure 229. Retrograde memory for public events in mild cognitive impairment and its relationship to anterograde memory and neuroanatomy. Neuropsychology. 2014 Nov;28(6):959-72.




Multiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier SchönmannMultiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier Schönmann